• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

Advances and Therapeutic Strategies in Targeted Delivery of Traditional Chinese Medicine for Drug-Induced Liver Injury

Corresponding author: XinXing Wang, wxxemail@sina.cn
DOI: 10.12201/bmr.202601.00026
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Drug-induced liver injury (DILI) is a leading cause of acute liver failure. Current Western medical treatment primarily relies on drug discontinuation and supportive therapy, lacking efficient broad-spectrum detoxification agents, while the efficacy of N-acetylcysteine is significantly time-limited. Traditional Chinese medicine (TCM) demonstrates therapeutic potential through multi-target regulation, but its clinical translation is severely constrained by the complexity of its components and the risk of hepatotoxicity. In response to these challenges, this article systematically reviews recent advances in targeted delivery technologies: engineered modifications of nanocarriers enhance selective drug accumulation in the liver; the design of microenvironment-responsive drug release systems enables precise controlled release at the lesion site; and the use of extracellular vesicles (EVs) leverages their innate targeting capability and low immunogenicity to reduce systemic exposure risks. These strategies provide crucial technical support and a translational pathway for the effective and safe application of TCM in the treatment of DILI.

    Key words: Drug-induced liver injury; Traditional Chinese medicine; Targeted delivery technology

    Submit time: 9 January 2026

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • Zhulei. Research Progress on Drug-induced Liver Injury with Immune Characteristics. 2025. doi: 10.12201/bmr.202504.00001

    ZhangJinmei, HuDandan. Paxlovid causing delayed drug-induced liver damage in a case and literature analysis. 2025. doi: 10.12201/bmr.202502.00033

    Zhu Xiaojing. . 2024. doi: 10.12201/bmr.202412.00015

    xieping. The Traditional Chinese Medicine Syndrome Differentiation and Treatment for Radiation-induced Vaginal Injury Based on Theory of Evil Hidden in Moyuan. 2025. doi: 10.12201/bmr.202511.00016

    wangminggang, luojuan, mozhengyuan, chenxinxin, wangxiufeng. The Role of Immune Cells and Traditional Chinese Medicine in Acute-on-Chronic Liver Failure. 2025. doi: 10.12201/bmr.202504.00030

    刘永珍, Wang ling, Liu Fu Ron. Medication patterns of traditional Chinese medicine in the treatment of radiotherapy-induced oral mucositis:A study based on data mining. 2025. doi: 10.12201/bmr.202504.00049

    fangjie, zhangaili. Research Advances in Clinical Treatment of Psoriasis: From Traditional Drugs to Biological Agents and Emerging Strategies. 2025. doi: 10.12201/bmr.202512.00051

    Research Progress on the Application of Traditional Chinese Medicine in Bowel Preparation Before Colonoscopy. 2026. doi: 10.12201/bmr.202601.00054

    lvshuzhen. Study on the Factors Influencing Patients Willingness to Use Chinese Medicine Delivery Service Based on Hospital WeChat Public Platform. 2022. doi: 10.12201/bmr.202209.00010

    Li Lingbing, Chen Xi. The Research Progress of Traditional Chinese Medicine Monomers in Precancerous Lesions of Gastric Cancer. 2025. doi: 10.12201/bmr.202511.00037

  • ID Submit time Number Download
    1 2025-11-04

    10.12201/bmr.202601.00026V1

    Download
  • Public  Anonymous  To author only

Get Citation

XinXing Wang. Advances and Therapeutic Strategies in Targeted Delivery of Traditional Chinese Medicine for Drug-Induced Liver Injury. 2026. biomedRxiv.202601.00026

Article Metrics

  • Read: 115
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误